Crow's Feet

18 clinical trials · Condition

Record	Firm	Date
ET-01 in Subjects With Lateral Canthal Lines, LCL-210 (NCT04985916)	Eirion Therapeutics Inc.	2021-07-19
Efficacy and Safety of DKB-119 in Patients in Crow's Feet (NCT06021418)	Dongkook Pharmaceutical Co., Ltd.	2020-11-02
A Study on the Anti-Wrinkle Efficacy Assessment and Safety Evaluation of the Cluster of Autologous Dermal Fibroblast on Bilateral Crow's Feet (NCT04818203)	S.Biomedics Co., Ltd.	2020-07-20
ET-01 in Subjects With Lateral Canthal Lines, LCL-208 (NCT03839693)	Eirion Therapeutics Inc.	2018-10-16
ET-01 in Subjects With Lateral Canthal Lines (NCT03326856)	Eirion Therapeutics Inc.	2017-10-25
Dose Finding Study In Subjects With Crow's Feet (NCT01951742)	Anterios Inc.	2013-09-01
Clinical Trial To Evaluate ANT-1207 In Subjects With Crow's Feet (NCT01358695)	Anterios Inc.	2011-05-01
Safety Study of Two Repeat Doses of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults (NCT01124565)	Revance Therapeutics, Inc.	2010-05-01
Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults (NCT01064518)	Revance Therapeutics, Inc.	2010-01-01
Efficacy and Safety Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines (NCT00968942)	Revance Therapeutics, Inc.	2009-08-01
Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines (NCT00968825)	Revance Therapeutics, Inc.	2009-07-01
Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines (NCT00888914)	Revance Therapeutics, Inc.	2008-11-01

Track Crow's Feet automatically

Every clearance here is in the API, with alerts when new ones post.